MonumenTAL-8

A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

Near Add Your Location

Barbara Ann Karmanos Cancer Institute
Wayne State University
Detroit, MI
  • Not yet accepting
Get personalized results in 60 seconds
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials
Medical College of Wisconsin
Froedtert Hospital
Milwaukee, WI
  • Not yet accepting
Norton Cancer Institute (St. Matthews)
St. Matthews Campus
Louisville, KY
  • Not yet accepting
Holden Comprehensive Cancer Center - University of Iowa
University of Iowa Hospitals and Clinics
Iowa City, IA
  • Not yet accepting
Abramson Cancer Center - University of Pennsylvania (UPENN)
University of Pennsylvania
Philadelphia, PA
  • Not yet accepting
Huntsman Cancer Institute
University of Utah
Salt Lake City, UT
  • Not yet accepting
UCSF Helen Diller Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
  • Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.